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MATERIALS	  &	  METHODS
WORKFLOW	  OVERVIEW
1.	   Ribosome	  proﬁling	   of	   ribosome	  captured	  mRNA	   fragments	  
performed	  on	  HiSeq,	  Illumina	  sequencing	  plaLorm	  (RIBO-­‐seq).	  
2.	   Quality	   control	   based	   on	   exisPng	   tools	   as	   FastQC	   and	  
custom	  metagenic	  funcPonal	  assessment.	  
3.	  Transcriptome	  mapping	  based	  on	  STAR	  [4]	  and/or	  TopHat2	  [5]	  
local	  aligners.
4.	   Single	   nucleoPde	   polymorphism	   (SNP)	   calling	   based	  
on	  samTools-­‐mpileup	  and/or	  GATK.
5.	  TranslaPon	  iniPaPon	  site	  (TIS)	  calling	  based	  on	  trained	  
Support	   Vector	   Machine	   (SVM)	   [2]	   or	   rule-­‐based	  
algorithm	  [1].
6.	  TranslaOon	  product	  assembly,	  taken	  into	  account	  the	  
SNP,	   TIS,	   INDEL	   awareness.	   Construct	   complete	  
proteome,	  opPonally	  combine	  with	  SwissProt.	  
7.	  MS-­‐based	   proteomics/pepOdomics	   using	  
SearchGui	  [6]	  and	  PepPdeShaker	  [7]	  tools.
8.	   Genome-­‐centric	   visualizaOon	   of	   all	  
generated	   informaPon	   tracks	   (Ensembl,	  
UCSC,	  IGV	  genome	  browsers).
=>	  All	  results	  are	  stored	  in	  a	  rela%onal	  SQLite	  
database	  allowing	  further	  detailed	  analysis.
An	  increasing	  number	  of	  studies	  involve	  integraOve	  analysis	  of	  
gene	   and	  protein	   expression	   data,	   taking	   advantage	   of	   new	  
technologies	   such	   as	   next-­‐generaPon	   transcriptome	  
sequencing	  (RNA-­‐Seq)	  and	  highly	  sensiPve	  mass	  spectrometry	  
(MS).	  Recently,	   a	   strategy,	   termed	  ribosome	   proﬁling,	   based	  
on	  deep	  sequencing	  of	  ribosome-­‐protected	  mRNA	  fragments,	  
indirectly	  monitoring	   protein	   synthesis,	   has	   been	   described.	  
When	  used	  in	  combinaPon	  with	  iniOaOon-­‐speciﬁc	   translaOon	  
inhibitors,	   it	   enables	   the	   idenPﬁcaPon	   of	   (alternaPve)	  
translaPon	  iniPaPons.	  
INTRODUCTION
RIBO-­‐seq	  experimental	  workﬂow	  [3]
In	   contrast	   to	   rouPnely	   employed	   protein	   databases	   in	  
proteomics	   searches,	   RIBO-­‐seq	   derived	   data	   gives	   a	   more	  
representaOve	   expression	   state	   and	   accounts	   for	   sequence	  
variaPon	   informaPon	   (single	   nucleoOde	   polymorphism,	  
inserOons,	  deleOons	  and	  RNA-­‐splice	  variants)	  and	  alternaOve	  
translaOon	   iniOaOon	   leading	   to	   N-­‐terminal	   extended	   and/or	  
truncated	   protein	   forms.	   Furthermore,	   RIBO-­‐seq	   reveals	  
translaPon	  start	  at	  near-­‐cognate	  start	  sites.	  Without	  taking	  this	  
informaPon	  into	  account,	  MS-­‐based	  proteomic	  studies	  may	  fail	  
to	  detect	  novel,	  important	  protein	  forms.MOA	  of	  iniOaOon-­‐speciﬁc	  translaOon	  inhibitors	  
and	  example	  of	  gene-­‐mapped	  RIBO-­‐seq	  signals	  [1,2]
GOALS
✓ Compile	  a	  sample-­‐speciﬁc	  protein	  search	  database	  based	  on	  ribosome	  proﬁling	  sequencing	  
data.
✓ Introduce	   new	   translaOon	   products	   in	   the	   MS	   search	   space:	   N-­‐terminal	   extensions/
truncaPons,	  trans-­‐lated	  uORFs,	  near-­‐cognate	  start	  sites. 
✓ Bridging	  two	  omics	  worlds:	  transcriptomics	  &	  MS-­‐based	  proteomics	  by	  means	  of	  RIBO-­‐seq.
✓ Deep	   proteome	   coverage	   based	   on	   ribosome	   proﬁling	   aids	   mass	  
spectrometry-­‐based	  protein	  and	  pepOde	  discovery	  and	  provides	  evidence	  
of	  alternaOve	  translaOon	  products	  and	  near-­‐cognate	  translaOon	  iniOaOon	  
events	  [1].
✓ Future	  work	  will	  mainly	  focus	  on	  :
èFurther	   invesPgaPon	  of	  the	  diﬀerenPal	  expression	  on	  translaPon	  level	  
of	   UniProtKB-­‐SwissProt	   and	   RIBO-­‐seq	   derived	   translaPon	   products:	  
technological	  and/or	   biological	   relevance?	  Detailed	  assessment	  of	   the	  
diﬀerence	   between	   in	   vivo	   measurement	   of	   protein	   synthesis	   (RIBO-­‐
seq)	  and	  protein	  presence	  (MS-­‐based	  proteomics).
èGeneralize	   the	   pipeline	   to	   all	   types	   of	   next-­‐generaPon	   sequencing	  
RNA-­‐seq	  data:	   (direcPonal)	  A+/A-­‐	  RNA-­‐seq,	  CLIP-­‐seq,	  exome-­‐seq,	  ribo-­‐
seq
èQuanOtaOve	   correlaOon	   of	   RIBO-­‐seq	   and	   (non)	   labelled	   MS-­‐based	  
proteomics
èIncorporate	  Pipeline	  into	  Galaxy-­‐P	  [9]
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MS	  experiments	  -­‐	  2	  Data	  Sets:








(A)	   COFRADIC:	   Pie	   charts	   depicPng	   the	   idenOﬁcaOon	   of	   novel	   translaOon	   products:	   N-­‐
terminal	  extensions	  truncaPons,	  uORF	  translaPons,	  internal	  out-­‐of-­‐frame	  translaPons	  (lev	  
panel	   is	   RIBO-­‐seq	   based,	   right	   panel	   is	   MS-­‐based	   using	   custom	   DB).	   (B)	   SHOTGUN:	   Pie	  
chart	   showing	   an	   +2.5%	   gain	   in	   protein	   idenOﬁcaOon	   using	   the	   combined	   RIBO-­‐seq	  
derived	   and	   SwissProt	   search	   database.	   (C)	   Weblogos	   depicPng	   the	   sequence	   context	  
(three	   bases	   upstream	   and	   four	   bases	   downstream)	   of	   the	   newly	   idenPﬁed	   translaPon	  
iniPaPon	  sites,	  clearly	  poinPng	  to	  near-­‐cognate	  translaOon	  iniOaOon.	  
Version	  1	  Custom	  DB	  [8]	  based	  on:	  
-­‐	  SVM	  based	  TIS	  calling	  [2]
-­‐	  Using	  reference	  genomic	  sequence
















































































Version	  2	  Custom	  DB	  based	  on:	  
-­‐	  rule-­‐based	  TIS	  calling	  [1]
-­‐	  Including	  SNP-­‐INDEL	  informaOon
-­‐	  Only	  Ribo-­‐Seq	  derived	  sequences
Examples:
(A)	   UCSC	   genome-­‐browser	   screenshot	   showing	   the	  extended	  
form	   of	   the	   Fxr2	   gene	   translaPon	   product	   starPng	   at	   near-­‐
cognate	   GTG	   start	   site.	   IdenPﬁed	   trypPc	   pepPde	   is	   also	  
depicted.	   (B)	   2	   examples	   of	   (a)syn-­‐onymous	   SNPs	   with	  
overlapping	   trypPc	   pepPde	   idenPﬁcaPon	   resulPng	   from	   the	  





synonymous	  mutaPon	  :	  Vps53	  gene
generic_Q9D7A6|uc008ekg.1_36|Q9D7A6      MACAAARSPADQDRFICIYPAYLNNKKTIAEGRRIPISKAVENPTATEIQDVCSAVGLNA
sp|Q9D7A6|SRP19_MOUSE                    MACSAARPPADQDRFIFIYPAYLNNKKTIAEGRRIPISKAVENPTATEIQDVCSAVGLNA
                                         ***:*** ******** *******************************************
generic_Q9D7A6|uc008ekg.1_36|Q9D7A6      FLEKNKMYSREWNRDVQFRGRVRVQLKQEDGSLCLVQFPSRKSVMLYVAEMIPKLKTRTQ
sp|Q9D7A6|SRP19_MOUSE                    FLEKNKMYSREWNRDVQFRGRVRVQLKQEDGSLCLVQFPSRKSVMLYVAEMIPKLKTRTQ
                                         ************************************************************
generic_Q9D7A6|uc008ekg.1_36|Q9D7A6      KSGGADPSLQQGEGSKKGKGKKKK
sp|Q9D7A6|SRP19_MOUSE                    KSGGADPILQQGEGSKKGKGKKKK
                                         ******* ****************









SVM based TIS calling (version 1, no SwissProt) OLD
SVM based TIS calling (version 1, + SwissProt) OLD
stringent rule based TIS calling New
stringent rule based TIS calling and SNP/INDEL aware NEW
shotgun identifications using custom protein DB protein * peptide * PSM *
SVM based TIS calling (version 1, no SwissProt) OLD 2194 14519 32818
SVM based TIS calling (version 1, + SwissProt) OLD 3252
stringent rule based TIS calling NEW 3295 15913 32348
stringent rule based TIS calling and SNP/INDEL aware NEW 3341 14967 32620
* 1% FDR level on protein, peptide and PSM level
